Hematology – The Novel Approaches

There has been an increased trend in adoption of haematology analyser for smaller and mid-sized laboratories over the years.  This is because they offer cost effective, accurate and time saving solutions. Hospitals and clinical laboratories are replacing manually intensive tasks by using automation which helps in reducing the chances of human error and thereby improving overall productivity. The results of these trend setting factors can be seen from the estimates which indicates that Haematology Analysers and Reagents Market size is estimated to grow by USD 3.91 billion at a CAGR of 6.95% between 2023 and 2028.... The modern-day analyzers are providing five to seven parts differential white-cell analysis, based on the different technologies, such as, electrical impedance, radiofrequency conductivity, light scatter, fluorescent scatter, and cytochemistry. In addition to this, they also provide additional information in the form, cell population data and Lymph Index using conductivity and scatter technology. Granularity Index, Large unstained cell population and hemoparasites which can be utilized in the screening of benign and malignant haematological conditions. In the past couple of years, several new products and technologies have emerged on the market, all of which promise to change the traditional understanding of laboratory hematology workflow and standards. New automated systems broaden capabilities beyond traditional methodologies that include cellular analysis combined with manual review. Fast moving product development, and active participation by large multinationals are providing unique solutions to evolving customer needs. In addition to development of technology, several new clinical parameters have been introduced to the complete blood count like NRBC, IG, IRF, IPF and RBC fragments together with parameters for detection of functional iron deficiency. Leucocyte positional parameters, which may diagnose specific diseases that detects malarial infection are now available. The novel approach is using monoclonal antibodies to measure the cells by flow cytometry. Moreover, during the Covid pandemic clinicians have abundantly used parameter like NLR. It is sensitive indicator of infection, inflammation, and sepsis, that can be used for confirming diagnosis/stratification, as well as its robust predictive and prognostic value. With all these the trends in the Hematology market are truly optimistic in coming years.